Personalis, Inc. (PSNL)
15.85
+0.03
(+0.19%)
USD |
NASDAQ |
Oct 23, 16:00
15.84
0.00 (0.00%)
After-Hours: 20:00
Personalis Enterprise Value : 1.511B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.511B |
| October 22, 2026 | 1.508B |
| October 21, 2026 | 1.517B |
| October 20, 2026 | 1.521B |
| October 19, 2026 | 1.514B |
| October 16, 2026 | 1.490B |
| October 15, 2026 | 1.520B |
| October 14, 2026 | 1.517B |
| October 13, 2026 | 1.511B |
| October 12, 2026 | 1.506B |
| October 09, 2026 | 1.527B |
| October 08, 2026 | 1.534B |
| October 07, 2026 | 1.527B |
| October 06, 2026 | 1.530B |
| October 05, 2026 | 1.570B |
| October 02, 2026 | 1.557B |
| October 01, 2026 | 1.545B |
| September 30, 2026 | 1.557B |
| September 29, 2026 | 1.564B |
| September 28, 2026 | 1.561B |
| September 25, 2026 | 1.576B |
| September 24, 2026 | 1.588B |
| September 23, 2026 | 1.564B |
| September 22, 2026 | 1.566B |
| September 21, 2026 | 1.553B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.570B |
| September 17, 2026 | 1.552B |
| September 16, 2026 | 1.539B |
| September 15, 2026 | 1.538B |
| September 14, 2026 | 1.558B |
| September 11, 2026 | 1.550B |
| September 10, 2026 | 1.562B |
| September 09, 2026 | 1.570B |
| September 08, 2026 | 1.591B |
| September 04, 2026 | 1.655B |
| September 03, 2026 | 1.616B |
| September 02, 2026 | 1.605B |
| September 01, 2026 | 1.640B |
| August 31, 2026 | 1.610B |
| August 28, 2026 | 1.641B |
| August 27, 2026 | 1.612B |
| August 26, 2026 | 1.642B |
| August 25, 2026 | 1.660B |
| August 24, 2026 | 1.640B |
| August 21, 2026 | 1.780B |
| August 20, 2026 | 1.621B |
| August 19, 2026 | 1.507B |
| August 18, 2026 | 1.305B |
| August 17, 2026 | 1.303B |
| August 14, 2026 | 1.319B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tempus AI, Inc. | 12.80B |
| 10X Genomics, Inc. | 8.848B |
| Alamar Biosciences, Inc. (California) | 1.931B |
| Champions Oncology, Inc. | 72.87M |
| Medpace Holdings, Inc. | 18.13B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.68M |
| Revenue (Quarterly) | 22.36M |
| Total Expenses (Quarterly) | 54.04M |
| EPS Diluted (Quarterly) | -0.3005 |
| Gross Profit Margin (Quarterly) | 21.21% |
| Profit Margin (Quarterly) | -141.7% |
| Earnings Yield | -6.88% |
| Normalized Earnings Yield | -6.883 |